CARDIOMEMS

cardiomems-logo

CardioMEMS is a medical device company that has developed and is commercializing a proprietary wireless sensing and communication technology for the human body. Their technology platform is designed to improve the management of severe chronic cardiovascular diseases such as heart failure and aneurysms. Their miniature wireless sensors can be implanted using minimally invasive techniques and transmit cardiac output, blood pressure and heart rate data that are critical to the management of patients.

#People #Financial #Website #More

CARDIOMEMS

Social Links:

Industry:
Health Care Medical Pharmaceutical

Founded:
2001-01-01

Address:
Atlanta, Georgia, United States

Country:
United States

Website Url:
http://www.cardiomems.com

Total Employee:
101+

Status:
Closed

Contact:
678-651-2300

Email Addresses:
info@cardiomems.com

Total Funding:
232.6 M USD

Technology used in webpage:
SPF Apple Mobile Web Clips Icon Domain Not Resolving Apache Mobile Non Scaleable Content Microsoft Exchange Online Amazon Office 365 Mail IPv6 JsDelivr



Current Advisors List

not_available_image

Marvin L. Woodall Board Member @ CardioMEMS
Board_member

lee-wrubel_image

Lee Wrubel Board Member @ CardioMEMS
Board_member

jan-garfinkle_image

Jan Garfinkle Investor @ CardioMEMS
Board_member

francisco-garcia_image

Francisco Garcia Board Observer @ CardioMEMS
Board_observer

not_available_image

Patrick J. Fortune Board Member @ CardioMEMS
Board_member
2005-05-01

not_available_image

Muhit Rahman Board Member @ CardioMEMS
Board_member
2001-07-01

Current Employees Featured

john-j-huntz_image

John J. Huntz
John J. Huntz Chairman & Director @ CardioMEMS
Chairman & Director
2006-09-01

not_available_image

Mark G. Allen
Mark G. Allen Co-founder, Chief Technology Officer, Director @ CardioMEMS
Co-founder, Chief Technology Officer, Director

not_available_image

David R. Stern
David R. Stern Senior Vice President, Scientific Affairs, Director @ CardioMEMS
Senior Vice President, Scientific Affairs, Director

Founder


not_available_image

Jay S. Yadav

not_available_image

Mark G. Allen

Investors List

st-jude-medical_image

St. Jude Medical

St. Jude Medical investment in Private Equity Round - CardioMEMS

vision-capital-advisors_image

Vision Capital Advisors

Vision Capital Advisors investment in Venture Round - CardioMEMS

boston-millennia-partners_image

Boston Millennia Partners

Boston Millennia Partners investment in Venture Round - CardioMEMS

foundation-medical-partners_image

Foundation Medical Partners

Foundation Medical Partners investment in Venture Round - CardioMEMS

medtronic_image

Medtronic

Medtronic investment in Venture Round - CardioMEMS

arcapita-ventures_image

Arcapita Ventures

Arcapita Ventures investment in Venture Round - CardioMEMS

aperture-venture-partners_image

Aperture Venture Partners

Aperture Venture Partners investment in Venture Round - CardioMEMS

arboretum-ventures_image

Arboretum Ventures

Arboretum Ventures investment in Venture Round - CardioMEMS

deerfield-management_image

Deerfield Capital Management

Deerfield Capital Management investment in Venture Round - CardioMEMS

easton-capital_image

Easton Capital

Easton Capital investment in Venture Round - CardioMEMS

Official Site Inspections

http://www.cardiomems.com

  • Host name: aa5dacf57429c8adc.awsglobalaccelerator.com
  • IP address: 13.248.172.93
  • Location: Seattle United States
  • Latitude: 47.6348
  • Longitude: -122.3451
  • Metro Code: 819
  • Timezone: America/Los_Angeles
  • Postal: 98109

Loading ...

More informations about "CardioMEMS"

CardioMEMS - Crunchbase Company Profile & Funding

CardioMEMS is a medical device company that has developed and is commercializing a proprietary wireless sensing and communication technology for the human body. Their …See details»

CardioMEMS Heart Failure System: An Up-to-Date Review - PMC

However, the CardioMEMS™ (Abbott Laboratories, Chicago, IL) HF system, an implantable microelectromechanical sensor, has emerged as an innovative solution, enabling real-time …See details»

CardioMEMS 2025 Company Profile: Valuation, …

CardioMEMS General Information Description. Provider of wireless sensing and communication technology for the human body. The company's technology …See details»

CardioMEMS, Inc. - LinkedIn

CardioMEMS, Inc. | 2,758 followers on LinkedIn. CardioMEMS is a medical device company that has developed and is commercializing a proprietary wireless sensing and communication …See details»

CardioMEMS - Company Profile - Tracxn

Feb 17, 2025 CardioMEMS develops and commercializes a wireless sensing and communication technology for the heart. The company's technology improves the …See details»

CardioMEMS - Funding, Financials, Valuation & Investors

How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Access exclusive financial …See details»

CardioMEMS: where we are and where can we go? - PMC

CardioMEMS is ... The prevalence of heart failure (HF) has been on the rise with associated increase in hospitalizations, morbidity and mortality. ... In a subgroup analysis of the …See details»

CardioMEMS in a Busy Cardiology Practice: Less than Optimal ...

CardioMEMS is an FDA-approved device that has been shown to significantly reduce heart failure hospital admission and improve the quality of life in New York Heart Association (NYHA) class …See details»

CardioMEMS HF System Product Overview | Abbott

The CardioMEMS™ HF System allows clinicians to monitor heart failure patients’ pulmonary artery (PA) pressure for proactive and actionable heart failure (HF) management and treatment. With early indications of worsening heart failure, …See details»

LIVE MORE WORRY LESS - Abbott Cardiovascular

CardioMEMS HF System. WATCH HER STORY. CardioMEMS isn’t just a guardian against heart failure; it’s a constant reassurance, turning what was once a fearful journey into a path filled …See details»

CardioMEMS HF System - heartfailure.abbott

Data-driven insights from the CardioMEMS™ HF System are an effective way to fine tune GDMT 1-3 for better patient outcomes in both HFrEF and HFpEF patients. The CardioMEMS HF …See details»

What Does Cardiomems Do? | Heart Health Revolution

Cardiomems is a groundbreaking system designed to improve the management of heart failure by continuously monitoring pulmonary artery pressure. This technology allows for real-time data …See details»

CardioMEMS Heart Failure System: An Up-to-Date Review - Cureus

Jan 22, 2025 This article explores the technical specifications, clinical efficacy, integration into clinical practice, and economic impact of the CardioMEMS system. Furthermore, we discuss …See details»

How the CardioMEMS Device Was Designed - MDDI Online

Aug 26, 2015 "For the CardioMEMS HF System, the benefit is observed when the data provided by the system is incorporated by the physician into the care of the patient." The company's …See details»

CardioMEMS | Columbus Regional Health - crh.org

The CardioMEMS HF System uses a miniaturized, wireless monitoring sensor that is implanted in the pulmonary artery during a minimally invasive procedure to directly measure PA pressure. …See details»

CardioMEMS Device: Advancements in Cardiovascular Monitoring

Jan 17, 2024 CardioMEMS is⁣ an innovative medical device that has shown ‌numerous evidence-based benefits in the management of ⁤heart failure. The device is implanted ⁢into …See details»

CardioMEMS Procedure for Heart Failure Patients

Nov 16, 2021 Trinity Health Michigan is a unified health care organization serving Michigan, offering the very best medicine and personalized care close to home. Close. Humana Insured …See details»

The Utility of CardioMEMS, a Wireless Hemodynamic Monitoring …

CardioMEMS, a wireless pulmonary artery pressure monitoring system, offers a promising method to monitor, manage, and decrease HF-related early and frequent readmissions in HF patients. …See details»

CardioMEMS: where we are and where can we go? - PubMed

The prevalence of heart failure (HF) has been on the rise with associated increase in hospitalizations, morbidity and mortality. These hospitalizations have led to increasingly more …See details»

2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the …

Feb 27, 2025 Fondaparinux, a synthetic pentasaccharide that selectively binds antithrombin and causes rapid and predictable inhibition of Factor Xa, was evaluated in patients with high-risk …See details»

linkstock.net © 2022. All rights reserved